FDA grants Fast Track designation to Liquidia's YUTREPIA for SSc-related Raynaud's phenomenonSep 3Regulatory milestoneLiquidia Corptreprostinil
Liquidia reports YUTREPIA sales growth, begins enrollment in L606 pivotal studyAug 12Quarterly updateLiquidia Corptreprostinil
Sign in